乳腺癌HER2检测技术的临床应用(3)
[7] Hameed O，Chhieng DC，Adams AL. Human epidermal growth factor receptor 2 testing in breast cancer：30% versus 10% cutoff for immunohistochemistry[J]. Arch Pathol Lab Med，2008，132(3)：319.[8] Gown AM，Goldstein LC，Barry TS，et al. High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer require a normalized IHC scoring system[J].Mod Pathol ......
您现在查看是摘要页，全文长 3120 字符。